参考文献/References:
[1] CHEN Weiwei, GAO Runlin, LIU Lisheng, et al. Chinacardiovascular diseases report 2015: a summary[J].Journal of Geriatric Cardiology, 2017, 14(1): 1-10.
[2] AGGARWAL M, AGGARWAL B, RAO J. Integrativemedicine for cardiovascular disease and prevention[J]. TheMedical Clinics of North America, 2017, 101(5): 895-923.
[3] G?N?REUX P, MEHRAN R, LEON M B, et al.Classification for assessing the quality of diagnosticcoronary angiography[J]. The Journal of InvasiveCardiology, 2017, 29(12): 417-420.
[4] RUPARELIA N, CHAI J T, FISHER E A, et al.Inflammatory processes in cardiovascular disease:a route to targeted therapies[J]. Nature ReviewsCardiology, 2017, 14(5): 314.
[5] AFARI M E, BHAT T. Neutrophil to lymphocyte ratio(NLR) and cardiovascular diseases: an update[J]. ExpertReview of Cardiovascular Therapy, 2016, 14(5): 573-577.
[6] MONTALESCOT G, SECHTEM U, ACHENBACHS, et al. 2013 ESC guidelines on the management ofstable coronary artery disease: the Task Force on themanagement of stable coronary artery disease of theEuropean Society of Cardiology. [J]. European HeartJournal, 2013, 34(38): 2949-3003.
[7] CANNON C P, BRINDIS R G, CHAITMAN B R, et al.2013 ACCF/AHA key data elements and definitions formeasuring the clinical management and outcomes ofpatients with acute coronary syndromes and coronaryartery disease:a report of the American College ofCardiology Foundation/American Heart AssociationTask Force on Clinical Data Standards(WritingCommittee to Develop Acute Coronary Syndromes andCoronary Artery Disease Clinical Data Standards)[J].Circulation, 2013, 127(9): 1052-1089.
[8] GENSINI G G. A more meaningful scoring system fordetermining the severity of coronary heart disease[J].The American Journal of Cardiology, 1983, 51(3): 606.
[9] MALLIKA V, GOSWAMI B, RAJAPPA M. Athero-sclerosis pathophysiology and the role of novel riskfactors: a clinicobiochemical perspective[J]. Angiology,2007, 58(5): 513-522.
[10] 王阳斌,夏茂,夏永泉.血浆 vWF,D- 二聚体水平与外周血中性粒细胞 / 淋巴细胞比值联合检测在血栓性疾病中的临床诊断价值[J].现代检验医学杂志,2019, 34(6):86-89.WANG Yangbin, XIA Mao, XIA Yongquan. Diagnosticvalue of vWF combined with D-dimer and peripheralblood NLR in the diagnosis of thrombotic disease[J].Journal of Modern Laboratory Medicine, 2019,34(6):86-89.
[11] 孟欣 , 胡辽辽 , 张宁 . 等 . 中性粒细胞 / 淋巴细胞比值在甲、乙型流感病毒感染患者预测价值分析 [J].国际检验医学杂志 , 2019, 40(20):2464-2467.MENG Xin, HU Liaoliao, ZHANG Ning, et al. Predictivevalue of neutrophil/lymphocyte ratio in patients infectedwith influenza A and B virus[J]. International Journal ofLaboratory Medicine, 2019, 40(20):2464-2467.
[12] 任党利,韩海燕,周鑫,等.中性粒细胞 / 淋巴细胞比值在区分不同病原菌引起血流感染的价值 [J].现代检验医学杂志 , 2017, 32(2):102-105.REN Dangli, HAN Haiyan, ZHOU Xin, et al. Clinicalevaluation on ratio of neutrophil-to-lymphocyte indifferent pathogens[J]. Journal of Modern LaboratoryMedicine, 2017, 32(2):102-105.
相似文献/References:
[1]韩瑞玲,李 艳,吴 薇.武汉地区冠心病患者氯吡格雷药物代谢相关基因CYP2C19的多态性分布分析[J].现代检验医学杂志,2015,30(03):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
HAN Rui-ling,LI Yan,WU Wei.Analysis of the Polymorphism Distribution of Clopidogrel Metabolism
Related Gene CYP2C19 in Patients with Coronary Artery Disease in Wuhan[J].Journal of Modern Laboratory Medicine,2015,30(06):21.[doi:10.3969/j.issn.1671-7414.2015.03.006]
[2]洪骏,王锋,印中鹏,等.冠心病患者血浆纤维蛋白原与脂蛋白相关磷脂酶A2水平[J].现代检验医学杂志,2015,30(05):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
HONG Jun,WANG Feng,YIN Zhong-peng,et al.Levels of Plasma Lipoprotein Associated Phospholipase A2
and Fibrinogen in Patients with Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):6.[doi:10.3969/j.issn.1671-7414.2015.05.003]
[3]赵佳a,姚创利a,左林,等.冠心病患者血清同型半胱氨酸对血脂和锰超氧化物歧化酶的影响[J].现代检验医学杂志,2015,30(05):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
ZHAO Jiaa,YAO Chuang-lia,ZUO Lin,et al.Effects of Homocysteine on Blood Lipid and Manganese Superoxide
Dismutase in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):44.[doi:10.3969/j.issn.1671-7414.2015.05.013]
[4]李 垚,杨 平.早发冠心病触珠蛋白水平及其在免疫调节中的作用研究[J].现代检验医学杂志,2015,30(01):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
LI Yao,YANG Ping.Role of Haptoglobin in the Immunomodulatory
in Patients with Premature Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2015,30(06):98.[doi:10.3969/j.issn.1671-7414.2015.01.027]
[5]张 蕾,陈 捷,陈玉婷.冠心病并发恶性肿瘤患者Ghrelin/obestatin比值变化及意义[J].现代检验医学杂志,2016,31(04):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
ZHANG Lei,CHEN Jie,CHEN Yu-ting.Change and Significance of Ghrelin/Obestatin in Patients
with Coronary Heart Disease Complicated with Malignant Tumor[J].Journal of Modern Laboratory Medicine,2016,31(06):104.[doi:10.3969/j.issn.16717-414.2016.04.029]
[6]赵 佳,左 林,姚创利,等.冠心病患者血清同型半胱氨酸水平与氧化应激的关系研究[J].现代检验医学杂志,2016,31(05):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
ZHAO Jia,ZUO Lin,YAO Chuang-li,et al.Study on the Relationship between Serum Homocysteine Levels
and Oxidative Stress in Patients with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(06):27.[doi:10.3969/j.issn.1671-7414.2016.05.007]
[7]姚创利,黎 阳,鲁旭娟,等.超氧化物歧化酶及其同工酶和超敏C-反应蛋白与冠心病的关系[J].现代检验医学杂志,2016,31(05):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
YAO Chuang-li,LI Yang,LU Xu-juan,et al.Relationship of Superoxide Dismutase Isoenzyme and High
Sensitive C-Reactive Protein with Coronary Heart Disease[J].Journal of Modern Laboratory Medicine,2016,31(06):73.[doi:10.3969/j.issn.1671-7414.2016.05.019]
[8]黄生金,郑利平,陆俊佳,等.广西地区壮族和汉族冠心病患者胱抑素C水平及其基因多态性的比较研究[J].现代检验医学杂志,2017,32(03):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
HUANG Sheng-jin,ZHENG Li-ping,LU Jun-jia,et al.Comparative Study of Cystatin C and Its Gene Polymorphism of Pati
ents
with Coronary Heart Disease between Zhuang and Han in Guangxi Region[J].Journal of Modern Laboratory Medicine,2017,32(06):26.[doi:10.3969/j.issn.1671-7414.2017.03.007]
[9]王跃帮,吴 娟,崔 倩,等.IL-6基因启动子区域-572C>G和-174G>C多态性与江苏宿迁汉族人群冠心病的相关性[J].现代检验医学杂志,2018,33(03):31.[doi:10.3969/j.issn.1671-7414.2018.03.010]
WANG Yue-bang,WU Juan,CUI Qian,et al.Association between Interleukin-6-572C>G
and -174G>C Gene Polymorphism in the Promoter Region
and Coronary Heart Disease of Han Population in Suqian of Jiangsu[J].Journal of Modern Laboratory Medicine,2018,33(06):31.[doi:10.3969/j.issn.1671-7414.2018.03.010]
[10]刘亚东,冯莉莉,王海晶,等.冠心病患者血清Lp-PLA2与HCY检测及其与冠状动脉病变程度的相关性分析[J].现代检验医学杂志,2018,33(06):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]
LIU Ya-dong,FENG Li-li,WANG Hai-jing,et al.Detection of Serum Lp-PLA2 and HCY in Patients with Coronary Heart Disease and Its Correlation with the Degree of Coronary Artery Disease[J].Journal of Modern Laboratory Medicine,2018,33(06):83.[doi:10.3969/j.issn.1671-7414.2018.06.022]